Welcome to LookChem.com Sign In|Join Free
  • or
3-(2,5-DIBROMOTHIEN-3-YL)PROPANOIC ACID is a synthetic organic compound with the molecular formula C9H9Br2O2S. It is a derivative of thiophene, featuring bromine and carboxylic acid functional groups. This unique structure endows it with a broad spectrum of applications in the chemical and pharmaceutical industries.

13191-40-7

Post Buying Request

13191-40-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13191-40-7 Usage

Uses

Used in Pharmaceutical Industry:
3-(2,5-DIBROMOTHIEN-3-YL)PROPANOIC ACID is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
3-(2,5-DIBROMOTHIEN-3-YL)PROPANOIC ACID is utilized as a key intermediate in the production of agrochemicals. Its properties contribute to the creation of effective and targeted agricultural products.
Used in Specialty Polymers and Materials:
3-(2,5-DIBROMOTHIEN-3-YL)PROPANOIC ACID is employed in the synthesis of specialty polymers and materials. Its incorporation enhances the properties of these materials, making them suitable for specific applications.
Used in Organic Electronics:
3-(2,5-DIBROMOTHIEN-3-YL)PROPANOIC ACID is used in the field of organic electronics as a component in the design of organic semiconductors and optoelectronic devices. Its unique structure allows for the development of advanced electronic components with improved performance.

Check Digit Verification of cas no

The CAS Registry Mumber 13191-40-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,9 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13191-40:
(7*1)+(6*3)+(5*1)+(4*9)+(3*1)+(2*4)+(1*0)=77
77 % 10 = 7
So 13191-40-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H6Br2O2S/c8-5-3-4(7(9)12-5)1-2-6(10)11/h3H,1-2H2,(H,10,11)

13191-40-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2,5-dibromothiophen-3-yl)propanoic acid

1.2 Other means of identification

Product number -
Other names 2,4-DICHLOROBENZAMIDINE HCL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13191-40-7 SDS

13191-40-7Downstream Products

13191-40-7Relevant academic research and scientific papers

Novel synthesis of thianinhydrin

Hauze, Diane B.,Joullie, Madeleine M.,Ramotowski, Robert,Cantu, Antonio

, p. 4239 - 4246 (1997)

The synthesis of the previously reported thianinhydrin (12) was achieved from 3-methylthiophene via the corresponding 5,6-dihydrocyclopenta[b]thiophen-4,6-dione (10). Conversion of 10 to the tricarbonyl (12) proceeded in good yield using dimethydioxirane oxidation of 5,6-dihydro-5-dimethyl aminomethylenecyclopenta[b]thiophen-4,6-dione (14). The fluorescence intensity of the zinc salt of the product of 12 and glycine was similar to that obtained from the product of ninhydrin and the same amino acid.

As hepatitis c inhibitor spiro compound and its use in medicine

-

, (2017/12/28)

The invention provides a spiro compound serving as a hepatitis c inhibitor and application thereof in a medicine. The compound is a compound as shown in a formula (I) or a stereisomer, a geometric isomer, a tautomer, nitric oxide, an aquo-complex, a solvate, a metabolite, pharmaceutically acceptable salt or prodrug of the compound as shown in the formula (I). The invention also provides a pharmaceutical composition containing the compound, application of the compound and the pharmaceutical composition in inhibition of HCV (Hepatitis C Virus) copy and HCV virus protein, as well as the application of the compound and the pharmaceutical composition in prevention, handling, treatment or relieving of HCV infection or hepatitis c disease for a patient. The formula I is as shown in the specification.

SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION

-

, (2014/06/23)

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.

REDUCTION DES CONTRAINTES STERIQUES (EMPECHEMENT A LA CONJUGAISON) DANS LES POLY(DIALKYL-3,4-THIOPHENES)

Garreau, R.,Roncali, J.,Garnier, F.,Lemaire, M.

, p. 93 - 98 (2007/10/02)

Cyclopenta thiophene, cyclopenta thiophene and thieno thiophene have been synthesized.The electropolymerization of these monomers was attempt.The electrical properties of poly(cyclopenta thiophene) are intermediate between those of poly(3-methylthiophene) and poly(3,4-dimethyl thiophene).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13191-40-7